Upgrade to SI Premium - Free Trial

Biogen Idec, Inc. (BIIB) Tops Q1 EPS by 34c; Boosts FY13 Outlook

April 25, 2013 6:31 AM
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q1 EPS of $1.97, $0.34 better than the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance Hot Earnings Hot Guidance

Next Articles